Simple and Smart Metal-Phenolic Micelles for Optimizing Immunotherapy by Disrupting Tumor Stemness

Area of Science:

• Immunology
• Nanotechnology
• Oncology

Background:

• The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is crucial for innate immunity and has therapeutic potential in antitumor immunotherapy.
• However, clinical applications are limited by negative feedback, including STING's paradoxical promotion of tumor stemness, which reduces treatment effectiveness.

Purpose of the Study:

• To develop a novel therapeutic strategy that overcomes STING-mediated tumor stemness to enhance cGAS-STING pathway-based antitumor immunotherapy.
• To create an intelligent drug delivery system for synergistic therapeutic effects.

Main Methods:

• Development of a metal-phenolic polymeric micelle (HMQ) encapsulating manganese ions (Mn2+) as a STING agonist and quercetin as a stemness inhibitor, stabilized by hyaluronic acid (HA).
• Characterization of HMQ's structure, drug release kinetics (pH-responsive), and targeting capabilities.
• Evaluation of HMQ's efficacy in mitigating STING-induced stemness and enhancing antitumor immune responses in preclinical models.

Main Results:

• HMQ effectively delivered Mn2+ and quercetin, coordinating them within a pH-responsive micelle structure.
• HMQ treatment significantly inhibited STING-induced tumor stemness.
• The combined therapy demonstrated amplified antitumor efficacy compared to individual components, highlighting a synergistic effect.

Conclusions:

• The developed HMQ system successfully addresses the therapeutic challenge posed by STING-induced tumor stemness.
• HMQ represents a promising new generation of cGAS-STING pathway agonists with enhanced therapeutic potential for cancer immunotherapy.
• This platform offers a flexible strategy for overcoming drug resistance and improving clinical outcomes in cancer treatment.